YHLO

YHLO (EST. 2008) is an innovative and steadfastly growing company headquartered in Shenzhen, China. In May of 2021, YHLO has successfully launched IPO and listed on Shanghai Stock Exchange (Stock code: 688575). To be a reliable and respected IVD enterprise, YHLO has put extensive investments in R&D and firmly associated with the top-tier universities, medical schools and research institutions worldwide on scientific studies. With over a decades continuous development expertise in immunoassays solution, YHLO may provide a broad range of instruments (based on Chemiluminescence, ELISA, Immunoblot and Immunofluorescnce methodologies) with patented technologies and outstanding features, as well as a comprehensive...

Medical,healthcare,immunology,immunoassay,chemiluminescence,esr,clinical medicine,autoimmunity,ivf,reproductive,international,clinical laboratory,in-vitro diagnostics,clinical diagnostics,medtech,listed company,and stock exchange

Yhlo operates in the Medical equipment manufacturing industry.

Yhlo's revenue is 11m - 100m

Yhlo has 51 - 200 employees.